CMS Seeks Public Input on Draft Guidance for Medicare Drug Price Negotiation Program
May 15, 2025
May 15, 2025
WASHINGTON, May 15 (TNSFR) -- The U.S. Department of Health and Human Services Centers for Medicare & Medicaid Services has released a notice inviting public comment on its newly issued draft guidance under the Inflation Reduction Act (IRA) concerning the Medicare Drug Price Negotiation Program.
Published in the Federal Register on May 15, 2025, the document outlines CMS' proposals for implementing the third negotiation cycle, the first cycle of renegotiation, and the effec . . .
Published in the Federal Register on May 15, 2025, the document outlines CMS' proposals for implementing the third negotiation cycle, the first cycle of renegotiation, and the effec . . .